On July 18, 2023, the Delhi High Court’s Division Bench issued an interim injunction supporting Indian startup RxPrism in a patent infringement suit against an Australia-based company CANVA, which offers comprehensive design solutions through its website. In the present matter, the Court concluded a prima facie case of infringement and passed an interim injunction order directing the Defendant to deposit a sum of INR 50 lakhs as a security for the Plaintiff’s claims for past use of the infringing feature and also awarded costs of Rs. 5 lakhs in favour of the Plaintiff owing to the language used in the written statement against the Plaintiff. The present article provides a comprehensive analysis of the case and the Court’s decision.